DOAC and NSAID bleeding risk — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — diclofenac increases bleeding risk when combined with rivaroxaban
NSAIDs increase bleeding risk with oral anticoagulants through gastrointestinal mucosal injury and platelet effects. This patient has additional bleeding risks from age, SSRI use and previous ulcer disease. OTC diclofenac supply would be inappropriate and safer analgesic options or clinical review should be discussed. The interaction is not reduced rivaroxaban absorption.
Reference: BNF